Strata™-X SPE Line Enhanced to Extract Neutral Drugs of Abuse in Forensic Toxicology

Phenomenex Inc., a global leader in the manufacture and research of advanced technologies for the separation sciences, introduces its second solid phase extraction (SPE) sorbent - Strata-X-Drug N, specially designed for the extraction of drugs of abuse in forensic toxicology. The new sorbent targets neutral drugs such as barbiturates and benzodiazepines. Similar to its counterpart for basic drug of abuse testing, Strata-X-Drug B, the new sorbent saves time and reduces solvent expense due to it requiring no conditioning or equilibration.

Stringent QC tests on Strata-X-Drug N products are carried out by Phenomenex; each batch is tested by extracting lorazepam and temazepam from actual urine samples, which delivers more realistic results than testing from spiked water. Samples prepared using Strata-X-Drug N are ready for LC or GC analysis, and methods are available using Phenomenex Kinetex® (LC) and Zebron® (GC) columns.

“Our QC processes use biological samples to ensure the sorbent will perform as expected in customer analyses,” explained Erica Pike, brand manager for Phenomenex. “User satisfaction and consumer adoption has been very high with Strata-X-Drug B, so we have no doubt that Strata-X-Drug N will follow suit.”

Strata-X-Drug N is offered in 1, 3, 6 and 12 mL SPE tubes and in 96-well plates. Additional information featuring the Strata-X-Drug SPE product family can be accessed via the company article page on the right.